AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Contribution of Diaphragmatic Ultrasound for Monitoring Diaphragmatic Function in Patients With Amyotrophic Lateral Sclerosis

Recruitingn/aAges 18 Years - anyAllCentre Hospitalier Universitaire Dijon
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease that occurs in adults. It is characterized by a progressive degeneration of the first and second motor neurons leading to muscle failure. In its spinal form, ALS manifests by a progressive worsening of limb involvement, whereas the bulbar form presents with swallowing disorders, dysarthria and feeding difficulties. Respiratory impairment is the most serious feature of ALS. Phrenic nerve damage causes diaphragmatic weakness, which inevitably leads to chronic restrictive respiratory failure. At the stage of symptomatic nocturnal or diurnal alveolar hypoventilation, non-invasive ventilation (NIV) prolongs survival while improving quality of life by relieving respiratory symptoms. The indication for the initiation of NIV is based on the appearance of respiratory symptoms but also on the demonstration of diaphragmatic insuf

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patient with Amyotrophic Lateral Sclerosis * Certain or probable according to the revised Escorial criteria * no indication for non-invasive ventilation * Adult patient * Patient who has given oral consent * Patient who speaks and reads French Exclusion Criteria: * Patients with pre-existing diaphragmatic dysfunction requiring non-invasive ventilation * Person who is not affiliated to national health insurance * Person subject to a legal protection measure (curatorship, guardianship) * Patients deprived of their liberty * Pregnant, parturient or breastfeeding women
๐Ÿ’Š

What it tests

  • Diaphragmatic ultrasound
  • Electro-physiological exploration of the diaphragm
๐Ÿ“

Where

1 site
Chu Dijon Bourogne
Dijon, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy